Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced the sale of a combination of twelve Quantum Sniffer™ QS-B220 desktop explosives and drugs trace detectors and Quantum Sniffer QS-H150 handheld explosives trace detectors to several U.S. Government agencies. The twelve units will be deployed for both civilian and military applications in building and facility security.
"These sales are a direct result of Implant Sciences' investment in U.S. Government sales and marketing. The demonstrated performance, reliability, and ease of use of our Quantum Sniffers are attracting increased awareness and acceptance with federal procurement officials. We anticipate that we will continue to grow our share of this important market," stated Implant Sciences' Vice President of Sales and Marketing, Dr. Darryl Jones.
"Our Quantum Sniffers have been recognized internationally as high-performing, high-value systems by governments and corporations around the globe. We are very pleased that our efforts to build U.S. Government market share is gaining traction. Our American-made products are well-positioned to serve the needs of our federal government and it is our hope to provide our systems and superior service on a broader level for both civilian and military purposes in the U.S. and worldwide at U.S. posts," added Implant Sciences' President and CEO, Glenn D. Bolduc.
Source: Implant Sciences Corp.
Date: Dec 3, 2012